Enter your login e-mail to the account
Search
- Neurologické projevy u mnohočetného myelomu
prof. MUDr. Zdeněk Ambler, DrSc.
(5/2008, Review articles )
- Klinická skúsenosť s liečbou mnohopočetného myelómu monoklonálnou protilátkou v monoterapii – kazuistika
MUDr. Natália Štecová
(4/2018, Original articles ) - Daratumumab across multiple myeloma treatment lines
MUDr. Juliana Holasová, Doc. MUDr. Ľubica Harvanová, PhD., MUDr. Iveta Simančíková, MUDr. Miriam Ladická, MUDr. Ľudmila Demitrovičová, PhD., MUDr. Emília Flochová, PhD., MUDr. Juraj Chudej, PhD., MBA, MUDr. Natália Štecová, PhD., MUDr. Tomáš Guman, PhD., MUDr. Alexander Wild, PhD.
(6/2023, Drugs & drug classes ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Treatment of multiple myeloma
MUDr. Emília Flochová, PhD., MUDr. Lucia Stančiaková
(5/2016, Spectrum ) - Current treatment options of transplant-ineligible patients with multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(3/2013, Focus ) - Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
doc. MUDr. Martin Mistrík, PhD., doc. MUDr. Angelika Bátorová, PhD., MUDr. Ľubica Roziaková, PhD.
(3/2014, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Classical and new prognostic factors and their impact on therapeutic procedures in DLBCL
doc. MUDr. Igor Andrašina, CSc., MUDr. Martin Petrilák
(3/2015, Spectrum ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Ixazomib, lenalidomide, dexamethasone in the treatment of patients with relapsed and refractory multiple myeloma
doc. MUDr. Juraj Sokol, PhD., MUDr. Juraj Chudej, PhD., MUDr. František Nehaj, MUDr. Lenka Lisá, PhD., MUDr. Matej Hrnčár, PhD., Prof. MUDr. Ján Staško, PhD.
(3/2020, Review articles ) - Treatment of relapsed and refractory myeloma
MUDr. Alexander Wild
(4/2013, Focus ) - HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMOPOIETIC CELL TRANSPLANTATION
MUDr. Ján Gyárfáš
(5/2008, Review articles ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Targeted therapics for bone sarcomas
MUDr. Peter Múdry, Ph.D.
(2/2011, Review articles ) - Panobinostat in treatment of multiple myeloma
MUDr. Miriam Ladická
(6/2017, Drugs & drug classes ) - Complications of multiple myeloma therapy and possibilities of their influencing
MUDr. Jan Hudeček, CSc., MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD., MUDr. Ivana Plameňová, PhD.
(5/2013, Focus ) - Four year continuation of treatment response in a patient with advanced myeloma–a case report
MUDr. Zdenka Štefániková, doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(S3/2018, Original works & case studies ) - Pomalidomide in heavily pretreated patient with multiple myeloma: a case report
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(S3/2018, Original works & case studies ) - Peripheral neuropathy in patients with multiple myeloma
MUDr. Juliana Gabzdilová, PhD., MUDr. Diana Horváthová, MUDr. Peter Zimmerman, MUDr. Kinga Dedinská, MUDr. Štefan Raffáč, PhD., MPH, prof. MUDr. PhDr. Peter Kalanin, PhD.
(1/2018, Review articles )
- Thrombosis and lymphoproliferative disorders
doc. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, PhD., MUDr. Matej Hrnčár, MUDr. Juraj Sokol, PhD., MUDr. Andrej Rosík
(2/2015, Review articles )